Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Isaacson KJ, Martin Jensen M, Subrahmanyam NB, Ghandehari H.

J Control Release. 2017 Aug 10;259:62-75. doi: 10.1016/j.jconrel.2017.01.034. Epub 2017 Jan 31.

PMID:
28153760
2.

The effects for PM2.5 exposure on non-small-cell lung cancer induced motility and proliferation.

Yang B, Chen D, Zhao H, Xiao C.

Springerplus. 2016 Dec 1;5(1):2059. eCollection 2016.

3.

Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.

Regier MC, Maccoux LJ, Weinberger EM, Regehr KJ, Berry SM, Beebe DJ, Alarid ET.

Biomed Microdevices. 2016 Aug;18(4):70. doi: 10.1007/s10544-016-0083-x.

4.

Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis.

Gopal SK, Greening DW, Zhu HJ, Simpson RJ, Mathias RA.

Sci Rep. 2016 Jun 21;6:28321. doi: 10.1038/srep28321.

5.

Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.

Kim D, Dai J, Park YH, Fai LY, Wang L, Pratheeshkumar P, Son YO, Kondo K, Xu M, Luo J, Shi X, Zhang Z.

J Biol Chem. 2016 Jul 29;291(31):16271-81. doi: 10.1074/jbc.M116.715797. Epub 2016 May 25.

6.

Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells.

Shin DH, Dier U, Melendez JA, Hempel N.

Biochim Biophys Acta. 2015 Dec;1852(12):2593-602. doi: 10.1016/j.bbadis.2015.09.001. Epub 2015 Sep 5.

7.

Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Ren F, Tang R, Zhang X, Madushi WM, Luo D, Dang Y, Li Z, Wei K, Chen G.

PLoS One. 2015 Aug 13;10(8):e0135544. doi: 10.1371/journal.pone.0135544. eCollection 2015. Review.

8.

Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.

Farooqui M, Bohrer LR, Brady NJ, Chuntova P, Kemp SE, Wardwell CT, Nelson AC, Schwertfeger KL.

Mol Cancer. 2015 Jul 29;14:138. doi: 10.1186/s12943-015-0408-z.

9.

Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

Radisky ES, Radisky DC.

Front Biosci (Landmark Ed). 2015 Jun 1;20:1144-63. Review.

10.

Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease.

Carver PI, Anguiano V, D'Armiento JM, Shiomi T.

Exp Toxicol Pathol. 2015 Feb;67(2):153-9. doi: 10.1016/j.etp.2014.11.004. Epub 2014 Dec 10.

11.

Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo.

Ågren MS, Schnabel R, Christensen LH, Mirastschijski U.

Eur J Cell Biol. 2015 Jan;94(1):12-21. doi: 10.1016/j.ejcb.2014.10.001. Epub 2014 Oct 23.

12.

Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health study.

Aroner SA, Rosner BA, Tamimi RM, Tworoger SS, Baur N, Joos TO, Hankinson SE.

Cancer Causes Control. 2014 Dec;25(12):1717-23. doi: 10.1007/s10552-014-0462-7. Epub 2014 Sep 16.

13.

Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.

Cierna Z, Mego M, Janega P, Karaba M, Minarik G, Benca J, Sedlácková T, Cingelova S, Gronesova P, Manasova D, Pindak D, Sufliarsky J, Danihel L, Reuben JM, Mardiak J.

BMC Cancer. 2014 Jun 28;14:472. doi: 10.1186/1471-2407-14-472.

14.

The Complex Interaction of Matrix Metalloproteinases in the Migration of Cancer Cells through Breast Tissue Stroma.

Davies KJ.

Int J Breast Cancer. 2014;2014:839094. doi: 10.1155/2014/839094. Epub 2014 Mar 27. Review.

15.

Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

Foley CJ, Fanjul-Fernández M, Bohm A, Nguyen N, Agarwal A, Austin K, Koukos G, Covic L, López-Otín C, Kuliopulos A.

Oncogene. 2014 Apr 24;33(17):2264-72. doi: 10.1038/onc.2013.157. Epub 2013 May 27.

16.

Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study.

Kim Y, Ollberding NJ, Shvetsov YB, Franke AA, Wilkens LR, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT.

Breast Cancer Res Treat. 2012 Dec;136(3):837-45. doi: 10.1007/s10549-012-2308-x. Epub 2012 Oct 31.

17.

Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.

Siletz A, Kniazeva E, Jeruss JS, Shea LD.

Cancer Microenviron. 2013 Apr;6(1):91-107. doi: 10.1007/s12307-012-0121-z. Epub 2012 Oct 23.

18.

Matrix metalloprotease-1a promotes tumorigenesis and metastasis.

Foley CJ, Luo C, O'Callaghan K, Hinds PW, Covic L, Kuliopulos A.

J Biol Chem. 2012 Jul 13;287(29):24330-8. doi: 10.1074/jbc.M112.356303. Epub 2012 May 9.

19.

Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers.

Conklin MW, Keely PJ.

Cell Adh Migr. 2012 May-Jun;6(3):249-60. doi: 10.4161/cam.20567. Epub 2012 May 1. Review.

20.

Bioengineering embryonic stem cell microenvironments for the study of breast cancer.

Raof NA, Mooney BM, Xie Y.

Int J Mol Sci. 2011;12(11):7662-91. doi: 10.3390/ijms12117662. Epub 2011 Nov 8. Review.

Supplemental Content

Support Center